.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Teva
Cerilliant
Mallinckrodt
QuintilesIMS
McKinsey
US Army
Boehringer Ingelheim
Merck
Baxter

Generated: June 27, 2017

DrugPatentWatch Database Preview

DEXTROAMPHETAMINE SULFATE Drug Profile

« Back to Dashboard

What is the patent landscape for Dextroamphetamine Sulfate, and when can generic versions of Dextroamphetamine Sulfate launch?

Dextroamphetamine Sulfate is a drug marketed by Actavis Elizabeth, Lannett, Able, Mast Mm, Purepac Pharm, Halsey, Novel Labs Inc, Mikart, Mylan Pharms Inc, Mallinckrodt, Mayne Pharma, Tris Pharma Inc, Avanthi Inc, Epic Pharma Llc, Barr, Nesher Pharms, Idt Australia Ltd, Sandoz, Outlook Pharms, Vitarine, Aurolife Pharma Llc, and Vintage Pharms Llc. and is included in twenty-seven NDAs.

The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There are seventeen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.

Summary for Tradename: DEXTROAMPHETAMINE SULFATE

Patents:0
Applicants:22
NDAs:27
Suppliers / Packagers: see list23
Clinical Trials: see list648
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEXTROAMPHETAMINE SULFATE at DailyMed

Pharmacology for Tradename: DEXTROAMPHETAMINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL040367-001Oct 31, 2002DISCNNoNo► Subscribe► Subscribe
Epic Pharma Llc
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL090652-001Mar 7, 2014DISCNNoNo► Subscribe► Subscribe
Aurolife Pharma Llc
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL202893-001Jul 31, 2013AARXNoNo► Subscribe► Subscribe
Vitarine
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL084986-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Aurolife Pharma Llc
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL202893-002Jul 31, 2013AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
US Army
Argus Health
Fuji
Dow
Cipla
Farmers Insurance
Fish and Richardson
Healthtrust
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot